Javascript is required for this site to function correctly.
Please enable Javascript support.

Snapshots of MJFF Recently Awarded Grants

The Foundation supports research that will lead to the creation of better Parkinson's treatments. Here are some of the patient-relevant projects the Foundation has recently funded.

If you are looking for a specific project, please search our Funded Grants Database.

Design of HdAd Type 5 LRRK2 Expression Vectors

Samuel M. Young, Jr. PhD
Institution: Max Planck Florida Institute
MJFF Program: Tools 2012
Attenuation of Neuroinflammation by Brain-targeted Liposomal Methylprednisolone (2B3-201) in Two Pre-clinical Models of Parkinson's Disease

Pieter J. Gaillard, PhD
Institution: to-BBB technologies
MJFF Program: Rapid Response Innovation Awards 2012
Marco de Boer, Phd
Institution: to-BBB technologies
MJFF Program: Rapid Response Innovation Awards 2012
William van Weperen MSc, MBA
Institution: to-BBB technologies
MJFF Program: Rapid Response Innovation Awards 2012
A Novel Protease Pathway in Parkinson’s Disease

G. Angus McQuibban, PhD
Institution: University of Toronto
MJFF Program: Rapid Response Innovation Awards 2012
A Small Molecule Approach to Correct Striatal Cholinergic Interneuron Dysfunction

Un Jung Kang, MD
Institution: The University of Chicago
MJFF Program: Rapid Response Innovation Awards 2012
Development of Small Molecule Hepatocyte Growth Factor Mimetics for the Treatment of Parkinson's Disease

Joseph W. Harding, PhD
Institution: Washington State University
MJFF Program: Rapid Response Innovation Awards 2012
John W. Wright, PhD
Institution: Washington State University
MJFF Program: Rapid Response Innovation Awards 2012
Krzysztof Czaja DVM, Phd
Institution: Washington State University
MJFF Program: Rapid Response Innovation Awards 2012
Next: Searchable Database of MJFF Awarded Grants
Print This Page Email This Page